PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Capital Expenditures (2021 - 2026)

PepGen (PEPG) posted Capital Expenditures of -$1000.0 for Q4 2025, down 101.03% sequentially from $97000.0 in Q3 2025, and down 100.44% YoY from $228000.0 in Q4 2024.

Analysis

PepGen (PEPG) Capital Expenditures (2021 - 2026) Analysis & Trends

PepGen has reported Capital Expenditures for 5 years, with the latest figure at -$1000.0 in Q4 2025.

  • Quarterly Capital Expenditures fell 100.44% year-over-year to -$1000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $139000.0 (down 75.57% YoY) and the FY2025 annual result came in at $264000.0, down 46.88% from the prior year.
  • Capital Expenditures slipped to -$1000.0 in Q4 2025 per PEPG's latest filing, from $97000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $1.6 million in Q1 2022 and troughed at -$1000.0 in Q4 2025.
  • A 5-year average of $380750.0 and a median of $184500.0 in 2023 frame the typical range for Capital Expenditures.
  • The sharpest annual moves came in 2022 and 2025: Capital Expenditures soared 3960.0% in 2022, then tumbled 100.44% in 2025.
  • Over 5 years, Capital Expenditures stood at $156000.0 in 2021, then surged by 606.41% to $1.1 million in 2022, then sank by 83.3% to $184000.0 in 2023, then advanced by 23.91% to $228000.0 in 2024, then slumped by 100.44% to -$1000.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods registered -$1000.0, $97000.0, and $43000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 37.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.29 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 25.02 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 34.68 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 251.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.26 Mn
10 PepGen 217.99 Mn 217.99 Mn - 30,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 30,000.00
Dec 31, 2025 -1,000.00
Sep 30, 2025 97,000.00
Jun 30, 2025 43,000.00
Mar 31, 2025 125,000.00
Dec 31, 2024 228,000.00
Sep 30, 2024 185,000.00
Jun 30, 2024 31,000.00
Mar 31, 2024 53,000.00
Dec 31, 2023 184,000.00
Sep 30, 2023 225,000.00
Jun 30, 2023 1.01 Mn
Mar 31, 2023 1.18 Mn
Dec 31, 2022 1.10 Mn
Sep 30, 2022 430,000.00
Jun 30, 2022 609,000.00
Mar 31, 2022 1.61 Mn
Dec 31, 2021 156,000.00
Sep 30, 2021 24,000.00
Jun 30, 2021 15,000.00